Cargando…
Development and characterization of a unique anti‐IgE mouse monoclonal antibody cross‐reactive between human and canine IgE
BACKGROUND: The efficacy assessment of human anti‐IgE monoclonal antibodies (mAbs) in animal models before clinical trials is hampered due to the lack of cross‐reactivity of anti‐IgE mAbs between species. OBJECTIVE: We developed CRE‐DR (an anti‐dog IgE monoclonal antibody), an anti‐IgE mouse mAb tha...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589357/ https://www.ncbi.nlm.nih.gov/pubmed/34533288 http://dx.doi.org/10.1002/iid3.531 |